Venous thromboembolism.
Mikihiro FujiyaPublished in: Nihon rinsho. Japanese journal of clinical medicine (2019)
Venous thromboembolism frequently occurs in patients with inflammatory bowel diseases (IBD) in western as well as Japan because of the alterations of congealing fibrinogenolysis system due to the refractory enteritis. Aging, disease activity, colorectal lesions, admission, central venous catheter and operations are risk factors for the development of venous thromboembolism. Aggressive treatments including preventive and therapeutic anti-coagulation are recommended in western countries. In Japan, it is needed to establish a consensus concerning the therapeutic strategy for venous thromboembolism in IBD patients.
Keyphrases
- venous thromboembolism
- disease activity
- direct oral anticoagulants
- systemic lupus erythematosus
- rheumatoid arthritis
- end stage renal disease
- ejection fraction
- rheumatoid arthritis patients
- south africa
- ankylosing spondylitis
- newly diagnosed
- emergency department
- prognostic factors
- peritoneal dialysis
- juvenile idiopathic arthritis
- patient reported outcomes
- clinical practice
- ulcerative colitis